SGH (SGH) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
12 Jun, 2026Executive summary
Achieved record FY25 revenue of A$10.7 billion, up 1% year-over-year, with EBIT up 8% to A$1.54 billion and NPAT up 9% to A$924 million, driven by strong industrial services and disciplined execution.
Operating cash flow increased 49% to A$1.95 billion, with EBITDA cash conversion over 90% in all Industrial Services businesses.
Total FY25 fully franked dividend increased 17% to $0.62 per share, supporting a 46% total shareholder return.
Completed full acquisition of Boral, reinforcing position as a leading diversified operating company.
Financial highlights
Revenue up 1% to A$10.7 billion; EBIT up 8% to A$1.54 billion; EBITDA up 6% to A$2.1 billion; EBIT margin expanded to 14.3%.
NPAT up 9% to A$924 million; statutory NPAT up 5% to A$486 million due to impairments.
Operating cash flow up 49% to A$1.95 billion; EBITDA cash conversion at 95%.
Dividend payout increased 17% year-over-year to $0.62 per share.
Net debt reduced to A$4.2 billion, leverage below 2x Net Debt/EBITDA.
Outlook and guidance
FY26 guidance targets low to mid single-digit EBIT growth, supported by margin expansion and robust customer activity.
WesTrac expects continued services growth, with capital sales normalizing.
Boral anticipates further earnings growth via operational momentum and efficiency.
Coates faces near-term variability but is positioned for medium-term rental demand uplift with Grow30 strategy.
Beach Energy production guidance for FY26 is 19.7–22.0 MMboe.
Latest events from SGH
- EBIT growth, margin expansion, and strong cash flow support buy-back and higher dividends.SGH
H2 2026 - Disciplined operator model, AI, and capital discipline drive 10% EBIT/EPS CAGR and 15% ROCE.SGH
Investor Day 2026 - Delivers 18% EBIT CAGR, robust asset integration, and targets further growth in FY26.SGH
Investor presentation - EBIT flat, NPAT up 2%, cash flow surged, and EBIT growth guidance reaffirmed.SGH
H1 2026 - Record FY25 earnings, dividend growth, and safety reforms drive strategic outperformance.SGH
AGM 2025 - Strong growth, sector focus shift, and rebranding to SGH highlighted at the 2024 AGM.SGH
AGM 2024 - Strong revenue and EBIT growth, margin expansion, and Boral integration drive robust outlook.SGH
H2 2024 - SGH sustains market outperformance with strong growth, margin focus, and strategic expansion.SGH
Company Presentation - Revenue, EBIT, and NPAT rose, margins expanded, and FY25 EBIT growth guidance is reaffirmed.SGH
H1 2025